PCM
KYNB icon

Prelude Capital Management’s Kyntra Bio KYNB Stock Holding History

Prelude Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-677
Closed -$45.7K – 1205
2023
Q2 		$45.7K Buy
+677
New +$280K ﹤0.01% 978
2021
Q4 		– Sell
-596
Closed -$152K – 2051
2021
Q3 		$152K Buy
596
+144
+32% +$51K ﹤0.01% 1430
2021
Q2 		$301K Buy
+452
New +$260K 0.01% 1192
2020
Q4 		– Sell
-98
Closed -$100K – 1504
2020
Q3 		$100K Sell
98
-78
-44% -$83.9K ﹤0.01% 906
2020
Q2 		$178K Buy
+176
New +$163K 0.01% 772
2020
Q1 		– Sell
-27
Closed -$29K – 1602
2019
Q4 		$29K Buy
27
+25
+1,250% +$25.5K ﹤0.01% 1505
2019
Q3 		$2K Buy
+2
New +$2.2K ﹤0.01% 1617
2019
Q1 		– Sell
-167
Closed -$226K – 1889
2018
Q4 		$193K Buy
+167
New +$188K 0.01% 742
2018
Q3 		– Sell
-42
Closed -$65K – 1818
2018
Q2 		$65K Buy
+42
New +$54.8K ﹤0.01% 1060
2018
Q1 		– Sell
-69
Closed -$82K – 1579
2017
Q4 		$82K Sell
69
-20
-22% -$25.1K 0.01% 835
2017
Q3 		$120K Buy
+89
New +$93.8K 0.01% 826
2016
Q3 		– Sell
-184
Closed -$86.7K – 1655
2016
Q2 		$75K Buy
184
+60
+48% +$27.5K 0.01% 859
2016
Q1 		$66K Buy
124
+24
+24% +$12K 0.01% 890
2015
Q4 		$76K Buy
+100
New +$66.4K 0.01% 912

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Prelude Capital Management's KYNB Position: Q3 2023 in Review

Prelude Capital Management sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 677 shares — an estimated $45.7K sold.

Prelude Capital Management first reported a position in KYNB in Q4 2015 and held it in 14 quarters. The position peaked at $301K in Q2 2021. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Prelude Capital Management reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Prelude Capital Management sold 677 Kyntra Bio shares in Q3 2023, an estimated $45.7K.
  • Prelude Capital Management first reported a position in Kyntra Bio in Q4 2015 and held it in 14 quarters.
  • Prelude Capital Management's Kyntra Bio position peaked at $301K in Q2 2021.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.